**US49446R1095 - REIT - After market: 18.01 0 (0%)**

Overall **KIM** gets a fundamental rating of **4** out of 10. We evaluated **KIM** against 210 industry peers in the **Equity Real Estate Investment Trusts (REITs)** industry. **KIM** scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, **KIM** is valued expensive at the moment.

ROA (0.55%) VS Industry: 6% outperformed.

0.03

26.09

ROE (1.04%) VS Industry: 5% outperformed.

0.08

135.39

Profit Margin (5.71%) VS Industry: 8% outperformed.

0.08

881.04

When comparing the current price to the book value of **KIM**, we can conclude it is valued correctly. It is trading at **1.17** times its book value.

Compared to an average industry price book ratio of 1.09, **KIM** is valued in line with its industry peers.

When comparing the **Enterprise Value to EBITDA** ratio of **KIM** to the average industry ratio of 15.65, **KIM** is valued in line with its industry peers.

With a **Price/Earnings Ratio** of **29.05**, **KIM** can be considered very expensive at the moment.

With a **Forward Price/Earnings Ratio** of **26.00**, **KIM** is valued very expensively.

Price/Earnings (29.05) VS Industry: 35% outperformed.

510.11

0.67

Price/Book (1.17) VS Industry: 47% outperformed.

46.45

0.08

Enterprise Value/ EBITDA (16.56) VS Industry: 42% outperformed.

128.53

2.05

The **Earnings Per Share** is expected to grow by **12.85%** on average over the next 5 years. This is quite good.

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The **Revenue** has been growing slightly by **4.91%** in the past year.

Measured over the past 5 years, **KIM** shows a small growth in **Revenue**. The Revenue has been growing by **7.55%** on average per year.

The **Revenue** is expected to grow by **1.93%** on average over the next 5 years.

The earnings per share for **KIM** have decreased strongly by **-61.25%** in the last year.

Measured over the past 5 years, **KIM** shows a very negative growth in **Earnings Per Share**. The EPS has been decreasing by **-28.93%** on average per year.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | -28.93% | -41.58% | -61.25% | 66.28% | 30.82% | 23.13% | 12.85% |

Revenue | 7.55% | 14.24% | 4.91% | 2.74% | 3.12% | 3.23% | 1.93% |

The Current Ratio of **KIM** is much better than the industry average of **0.74**.

When comparing the Quick Ratio to an average industry Quick Ratio of **0.66**, **KIM** is better placed than the average industry peer to meet its short term obligations.

The Debt to Equity ratio of **KIM** is way better than the industry averages.

When comparing the Altman-Z score to an average industry score of **0.73**, **KIM** is in better financial health than the average industry peer.

A Quick Ratio of **1.39** indicates that **KIM** should not have too much problems paying its short term obligations.

Debt/Equity (0.75) VS Industry: 70% outperformed.

21.53

0.00

Quick Ratio (1.39) VS Industry: 71% outperformed.

0.00

90.22

Current Ratio (1.39) VS Industry: 70% outperformed.

0.00

90.22

Altman-Z (0.98) VS Industry: 63% outperformed.

-0.94

37.03

Compared to an average industry **Dividend Yield** of **4.94**, **KIM** is paying slightly less dividend.

The dividend of **KIM** decreases each year by **-15.74%**.

Dividend Yield (4.31%) VS Industry: 35% outperformed.

0.27

13.72

NYSE:KIM (3/24/2023, 7:00:00 PM)**+0.5 (+2.86%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupReal Estate

GICS IndustryEquity Real Estate Investment Trusts (REITs)

Earnings (Last)02-09 2023-02-09/bmo

Earnings (Next)04-26 2023-04-26/bmo

Inst Owners95.58%

Inst Owner Change1.92%

Ins Owners2.2%

Ins Owner Change6.23%

Market Cap11.14B

Analysts74.81

Price Target24.27 (34.76%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 4.31% |

Dividend Growth(5Y)-15.74%

DP552.61%

Div Incr Years2

Div Non Decr Years2

Ex-Date03-08 2023-03-08 (0.23)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)38.69%

Min EPS beat(2)-51.63%

Max EPS beat(2)129.01%

EPS beat(4)2

Avg EPS beat(4)-3.55%

Min EPS beat(4)-239.95%

Max EPS beat(4)148.36%

Revenue beat(2)2

Avg Revenue beat(2)2.29%

Min Revenue beat(2)2.02%

Max Revenue beat(2)2.55%

Revenue beat(4)4

Avg Revenue beat(4)1.94%

Min Revenue beat(4)1.43%

Max Revenue beat(4)2.55%

PT rev (1m)-0.49%

PT rev (3m)-0.27%

EPS NQ rev (1m)2.92%

EPS NQ rev (3m)0%

EPS NY rev (1m)-2.01%

EPS NY rev (3m)-2.01%

Revenue NQ rev (1m)0.14%

Revenue NQ rev (3m)0.84%

Revenue NY rev (1m)0.86%

Revenue NY rev (3m)0.86%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 29.05 | ||

Fwd PE | 26 | ||

P/S | 6.45 | ||

P/FCF | 30.39 | ||

P/OCF | 12.94 | ||

P/B | 1.17 | ||

P/tB | 1.17 | ||

EV/EBITDA | 16.56 |

EPS(TTM)0.62

EY3.44%

EPS(NY)0.69

Fwd EY3.85%

FCF(TTM)0.59

FCFY3.29%

OCF(TTM)1.39

OCFY7.73%

SpS2.79

BVpS15.38

TBVpS15.38

PEG (NY)0.44

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.55% | ||

ROE | 1.04% | ||

ROIC | 2.58% | ||

ROICexc | 2.61% | ||

ROICexgc | 2.64% | ||

OM | 33.12% | ||

PM | 5.71% | ||

GM | 69.27% |

ROICexgc(3y)2.34%

ROICexcg growth 3Y-8.36%

ROICexcg growth 5Y-1.9%

ROICexc(3y)2.32%

ROICexc growth 3Y-8.2%

ROICexc growth 5Y-1.8%

OM growth 3Y-4.96%

OM growth 5Y-0.35%

PM growth 3Y-41.91%

PM growth 5Y-28.64%

GM growth 3Y-0.78%

GM growth 5Y-1.34%

F-Score6

Asset Turnover0.1

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.75 | ||

Debt/FCF | 19.52 | ||

Debt/EBITDA | 6.64 | ||

Cap/Depr | 97.92% | ||

Profit Quality | 371.93% | ||

Current Ratio | 1.39 | ||

Quick Ratio | 1.39 | ||

Altman-Z | 0.98 |

F-Score6

WACC6.65%

ROIC/WACC0.4

Cap/Depr(3y)128.28%

Cap/Depr(5y)143.63%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y-61.25%

EPS 3Y-41.58%

EPS 5Y-28.93%

EPS growth Q2Q192.31%

EPS Next Y66.28%

EPS Next 2Y30.82%

EPS Next 3Y23.13%

EPS Next 5Y12.85%

Revenue growth 1Y4.91%

Revenue growth 3Y14.24%

Revenue growth 5Y7.55%

Revenue growth Q2Q3.57%

Revenue Next Year2.74%

Revenue Next 2Y3.12%

Revenue Next 3Y3.23%

Revenue Next 5Y1.93%

EBIT growth 1Y5.63%

EBIT growth 3Y8.57%

EBIT growth 5Y7.17%

EBIT Next Year120.5%

EBIT Next 3Y30.68%

EBIT Next 5Y18.73%

FCF growth 1Y322.54%

FCF growth 3Y38.5%

FCF growth 5Y34.5%

OCF growth 1Y39.14%

OCF growth 3Y13.85%

OCF growth 5Y6.99%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*